IBM at Credit Suisse Conference Notes

posted in: Notes | 0

Martin Schroeter – SVP & CFO

There’s so much data being created that you can’t just program a computer to find the relationships that you’re looking for

“the amount of data that our clients have already and quite frankly the amount of data they’re creating everyday in order to — when they run their businesses and in order to help them understand their clients and how they serve their clients best is creating an opportunity for us where we can no longer, nobody can any longer just program a computer to find relationships that you’re looking for. It’s just too much data and so in a world where a system has to learn about the data, you have to find a way to interact with it. That’s roughly for a non-technical person, that’s roughly what we’re talking about when we say a system where cognitive will influence and affect every decision that companies will make over time. So the world of cognitive is here because of the amount of data that our clients and companies already have as well as how much is being created by the world today.”

Cognitive requires an amount of compute power that is only available in the cloud

“Now all of that requires an amount of compute and amount of power that is not available for everyone to invest in, but that’s where the cloud comes in and so there is obviously an economic element to moving into a cloud environment, but more importantly for our clients, we see an ability for access to these kinds of cognitive applications as well as an agility that you get from your business and running in a cloud environment.”

The only way to thrive in healthcare today is to have a system that can ingest all of the data that exists

“Therefore in our view the only way to survive, the only way to thrive, the only way to deliver proper healthcare is you have to have a system — cognitive system that can ingest all of the data that exists today in a way that allows you to get the right method of treatment soon, that allows you to get the right linkages and the right clinical trials early and in a complete way, so that you can put together, you can put together that string of treatment and fit within whatever that envelope happens to be when that payer decides in total how much they’re going to allocate.”